Dogwood Therapeutics, Inc. (DWTX) Form S-3 — Oct 30, 2026
Dogwood Therapeutics filed an S-3 registering for resale 4,098,360 shares held by Sealbond Limited, its controlling stockholder, which bought the shares at $1.22 per share in a $5.0 million private placement that closed October 26, 2026. The company receives no proceeds from any resale; the registration satisfies obligations under an October 19, 2026 Registration Rights Agreement. Sealbond beneficially owns approximately 67.8% of the 38.2 million shares outstanding (57.1% if all registered shares are sold), and affiliate Conjoint, Inc. holds about 7.4%, giving the CK Life Sciences group effective control of the company.
Key figures
- Gross Proceeds
- $5.0 million (private placement; company receives no resale proceeds)
- Offering Price
- 1.22
- Shares Offered
- 4098360
- Shares Outstanding
- 38227913
- Warrant shares
- 4386892
- Conjoint ownership pct
- 7.4
- Option shares issuable
- 1846227
- Sealbond ownership pct
- 67.8
- Share price oct28 2026
- 1.24
- Warrant avg exercise price
- 3.28
- Sealbond ownership after pct
- 57.1
- Potential warrant proceeds usd
- 14400000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.